Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. P2769

   Selection of EUCAST disk potency for WCK 4282 (cefepime-tazobactam, FEP-TAZ) susceptibility testing against Enterobacterales and Pseudomonas aeruginosa

   Sachin Bhagwat, Aurangabad, India

   Jiji Joseph , Erika Matuschek , Raju Thombre , Hemant Khande , Suyog Vaidya , Snehal Palwe , Hariharan Periasamy , Helio S. Sader , Jane Ambler , Sachin Bhagwat , Mahesh Patel , Gunnar Kahlmeter

   16 April 2019

   Session: Disk diffusion sucseptibility testing

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   New Antibacterial Agents & Stewardship

2. P2770

   Selection of EUCAST disk potency for WCK 5222 (cefepime-zidebactam, FEP-ZID) susceptibility testing against Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii

   Sachin Bhagwat, Aurangabad, India

   Ajabrao Kute , Erika Matuschek , Melroy Tellis , Hemant Khande , Suyog Vaidya , Snehal Palwe , Hariharan Periasamy , Helio S. Sader , Jane Ambler , Sachin Bhagwat , Mahesh Patel , Gunnar Kahlmeter

   16 April 2019

   Session: Disk diffusion sucseptibility testing

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   New Antibacterial Agents & Stewardship

3. O1063

   WCK-771 (INN: levonadifloxacin): pharmacodynamic index (PDI) and PD target (PDT) determination studies involving methicillin /quinolone-resistant Staphylococcus aureus (MRSA/QRSA) employing neutropenic mouse lung infection model

   Sachin Bhagwat, Aurangabad, India

   Pavan Tayde , Kushal Umarkar , Amol Kulkarni , Jaykumar Satav , Swapna Takalkar , Hariharan Periasamy , Rajesh Chavan , Vineet Zope , Sachin Bhagwat , Mahesh Patel

   16 April 2019

   Session: Defining exposure, efficacy and safety of new antimicrobial agents

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   New Antibacterial Agents & Stewardship

4. P1941

   Pharmacokinetic-pharmacodynamic (PK-PD) target attainment analyses to support WCK-771 (INN: levonadifloxacin) clinical dose selection

   Sachin Bhagwat, Aurangabad, India

   Vijay Ivaturi , Jogarao Gobburu , Swapna Takalkar , Hariharan Periasamy , Rajesh Chavan , Sachin Bhagwat , Mahesh Patel

   15 April 2019

   Session: Recent research on the pharmacokinetics and safety of antibacterial agents

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   New Antibacterial Agents & Stewardship

5. OS1016

   WCK 4282 [high-dose Cefepime (FEP)-Tazobactam (TAZ)]: In-vivo PK/PD studies identifying TAZ threshold concentrations (CT) against AmpC P. aeruginosa (PA)

   Sachin Bhagwat, Aurangabad, India

   Swapna Takalkar, Kushal Umarkar, Jaykumar Satav, Amol Kulkarni, Pavan Tayde, Rajesh Chavan, Sachin Bhagwat, Mahesh Patel

   25 April 2017

   Session: PK/PD: what you need to learn for new and old-revived antibiotics

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   New Antibacterial Agents & Stewardship

6. OS1017

   WCK 4873 (Nafithromycin): PK/PD analysis for H. influenzae (HI) through murine lung infection model

   Sachin Bhagwat, Aurangabad, India

   Jaykumar Satav, Swapna Takalkar, Kushal Umarkar, Rajesh Chavan, Anasuya Patel, Sachin Bhagwat, Mahesh Patel

   25 April 2017

   Session: PK/PD: what you need to learn for new and old-revived antibiotics

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   New Antibacterial Agents & Stewardship

7. P1350

   WCK 4873 (Nafithromycin): Impact of hyper ermB induction in S. pneumoniae and S. aureus on the activity of ketolides

   Sachin Bhagwat, Aurangabad, India

   Hemant Khande, Jaykumar Satav, Amol Kulkarni, Sachin Bhagwat, Mahesh Patel

   24 April 2017

   Session: Various agents against Gram-positive bacteria

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Poster presentation

   New Antibacterial Agents & Stewardship

8. P1302

   A novel beta-lactam enhancer Gram-negative antibiotic, zidebactam (ZID) - phenotypic and genotypic characteristics of ZID-selected mutants of Enterobacteriaceae - expressing Class C, KPC and NDM

   Sachin Bhagwat, Aurangabad, India

   Joshi Prashant, Hemant Khande, Snehal Palwe, Sneha Biniwale, Sachin Bhagwat, Mahesh Patel

   24 April 2017

   Session: Zidebactam and other new Gram-negative antibiotic potentiators

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Poster presentation

   New Antibacterial Agents & Stewardship

9. P1302

   Young doctors’ perspectives on antibiotic use and resistance in Europe in 2015 (YPAR): preliminary results

   Bojana Beovic, Ljubljana, Slovenia

   B. Beovic, M. Doušak, C. Pulcini, B. Guillaume, V. Vlahović Palčevski, D. Kofteridis, T. Kostyanev, B. Carević, J. Cortez, A. Wechsler-Fördös, L. Pagani, M. Klešnik, K. Nadrah, S. Uhan, D. Nathwani, E. (ESCMID Study Group for Antibiotic Policies), T. ESCMID

   11 April 2016

   Session: Education and competencies in antimicrobial stewardship

   Relevance:

    

   100%

    

   

   Event: ECCMID 2016
   Amsterdam, The Netherlands
   Poster presentation

   New Antibacterial Agents & Stewardship

10. P1264

    WCK 4282 (high-dose Cefepime-Tazobactam): Complimentary features drive efficacy against KPC-producing pathogens

    Sachin Bhagwat, Aurangabad, India

    H. Khande, J. Prashant, S. Palwe, K. Umarkar, S. Takalkar, S. Bhagwat, M. Patel

    11 April 2016

    Session: Cefepime-tazobactam

    Relevance:

     

    100%

     

    

    Event: ECCMID 2016
    Amsterdam, The Netherlands
    Poster presentation

    New Antibacterial Agents & Stewardship